Melnichenko G - Search Results

1

Effects of active acromegaly on bone mRNA and microRNA expression patterns.

Belaya Z, Grebennikova T, Melnichenko G, Nikitin A, Solodovnikov A, Brovkina O, Grigoriev A, Rozhinskaya L, Lutsenko A, Dedov I. Belaya Z, et al. Among authors: melnichenko g. Eur J Endocrinol. 2018 Apr;178(4):353-364. doi: 10.1530/EJE-17-0772. Epub 2018 Jan 26. Eur J Endocrinol. 2018. PMID: 29374071

2

Contraception in perimenopausal women with diabetes mellitus.

Grigoryan OR, Grodnitskaya EE, Andreeva EN, Shestakova MV, Melnichenko GA, Dedov II. Grigoryan OR, et al. Gynecol Endocrinol. 2006 Apr;22(4):198-206. doi: 10.1080/09513590600624317. Gynecol Endocrinol. 2006. PMID: 16723306 Clinical Trial.

3

Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women.

Belaya ZE, Melnichenko GA, Rozhinskaya LY, Fadeev VV, Alekseeva TM, Dorofeeva OK, Sasonova NI, Kolesnikova GS. Belaya ZE, et al. Hormones (Athens). 2007 Jan-Mar;6(1):62-70. Hormones (Athens). 2007. PMID: 17324919 Free article.

4

Effect on carbohydrate metabolism and analysis of acceptability (menstrual cycle control) of extended regimens of the vaginally inserted hormone-releasing system 'NuvaRing' as compared with the standard 21/7 regime in reproductive-age women with type 1 diabetes mellitus.

Grodnitskaya EE, Grigoryan OR, Klinyshkova EV, Andreeva EN, Melnichenko GA, Dedov II. Grodnitskaya EE, et al. Gynecol Endocrinol. 2010 Sep;26(9):663-8. doi: 10.3109/09513591003686296. Gynecol Endocrinol. 2010. PMID: 20334583 Clinical Trial.

5

Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.

Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II. Fadeyev VV, et al. Hormones (Athens). 2010 Jul-Sep;9(3):245-52. doi: 10.14310/horm.2002.1274. Hormones (Athens). 2010. PMID: 20688622 Free article. Clinical Trial.

6

Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II. Belaya ZE, et al. Endocrine. 2012 Jun;41(3):494-500. doi: 10.1007/s12020-012-9658-3. Epub 2012 Mar 25. Endocrine. 2012. PMID: 22447310

7

Practical evaluation of late-night salivary cortisol: a real-life approach.

Belaya ZE, Melnichenko GA. Belaya ZE, et al. Endocrine. 2012 Aug;42(1):222-3; author reply 224-5. doi: 10.1007/s12020-012-9709-9. Endocrine. 2012. PMID: 22644839 No abstract available.

8

Effect of metformin on the level of anti-Mullerian hormone in therapy of polycystic ovary syndrome in obese women.

Grigoryan O, Absatarova J, Andreeva E, Melnichenko G, Dedov I. Grigoryan O, et al. Among authors: melnichenko g. Minerva Ginecol. 2014 Feb;66(1):85-9. Minerva Ginecol. 2014. PMID: 24569407 Clinical Trial.

9

The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.

Belaya ZE, Hans D, Rozhinskaya LY, Dragunova NV, Sasonova NI, Solodovnikov AG, Tsoriev TT, Dzeranova LK, Melnichenko GA, Dedov II. Belaya ZE, et al. Among authors: melnichenko ga. Arch Osteoporos. 2015;10:44. doi: 10.1007/s11657-015-0244-1. Epub 2015 Nov 25. Arch Osteoporos. 2015. PMID: 26608406

10

Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing's syndrome.

Belaya ZE, Iljin AV, Melnichenko GA, Solodovnikov AG, Rozhinskaya LY, Dzeranova LK, Dedov II. Belaya ZE, et al. Among authors: melnichenko ga. Bonekey Rep. 2016 Jun 15;5:815. doi: 10.1038/bonekey.2016.42. eCollection 2016. Bonekey Rep. 2016. PMID: 27347399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page